|
GERMLINE AND CANCER SUBTYPES FOR MONITORING AND TREATMENT
GERMLINE AND CANCER SUBTYPES FOR MONITORING AND TREATMENT
Researchers at Stanford have developed practical applications that use germline information (e.g., germline epitope burden) for diagnosis, monitoring and treatment of cancer.
Cancer represents a wide spectrum of molecularly and morphologically diverse diseases. Individuals with the same...
Published: 10/26/2023
|
Inventor(s): Christina Curtis, Kathleen Houlahan
Keywords(s): Cancer, Immunotherapy
Category(s): Technology Classifications > Biology
|
|
AUTOANTIBODIES AS BIOMARKERS FOR LIPODYSTROPHY
AUTOANTIBODIES AS BIOMARKERS FOR LIPODYSTROPHY
Researchers at UCSF and the Chan Zuckerberg Biohub have developed methods to identify a subject that is at risk of developing autoimmune-related lipodystrophy.
Lipodystrophy is a clinical phenotype defined by a reduction in subcutaneous fat or adipose tissue. Excessive fat loss can lead to an imbalance...
Published: 12/5/2024
|
Inventor(s): Caleigh Mandel-Brehm, Joseph DeRisi, Mark Anderson
Keywords(s): Antibody, Autoantibody, Autoimmune, Biomolecules, Diagnosis, IgG, Immunotherapy, Lipodystrophy
Category(s): Technology Classifications > Biology
|
|
METHODS FOR PREDICTING THE RESPONSE TO METHOTREXATE AND TREATING RHEUMATOID ARTHRITIS
METHODS FOR PREDICTING THE RESPONSE TO METHOTREXATE AND TREATING RHEUMATOID ARTHRITIS
Researchers at UCSF have developed methods of treating Rheumatoid arthritis and for predicting the response of patients to methotrexate.
Rheumatoid arthritis (RA) is an autoimmune disease that leads to inflammation and destruction of joints, as well as other...
Published: 3/17/2023
|
Inventor(s): Renuka Nayak, Peter Turnbaugh
Keywords(s): Diagnosis, Immunotherapy
Category(s): Technology Classifications > Biology
|
|
METHODS, COMPOSITIONS AND SYSTEMS FOR PROFILING OR PREDICTING IMMUNE RESPONSE
METHODS, COMPOSITIONS AND SYSTEMS FOR PROFILING OR PREDICTING IMMUNE RESPONSE
Researchers at Avail Bio, Inc., UCSF and the Chan Zuckerberg Biohub have developed a proteomic technology for capturing the immune response against non-wild type antigens.
Immuno-oncologic research demonstrating tumor recognition by the immune system has led to the development...
Published: 6/1/2023
|
Inventor(s): Nima Emami, Clinton Cario, Joseph DeRisi, John Witte
Keywords(s): Antibody, Cancer, Immunotherapy, Oncology, Particle Display
Category(s): Technology Classifications > Biology
|
